Morningside Venture Investments
Morningside Venture Investments is an investment group that provides industry investments and social responsibility.
Business Model:
Revenue: $45.8M
Employees: 51-200
Rankings
Detailed Morningside Venture Investments Information
Geographic Data
Address: 2-20 Paterson Street
City: Causeway Bay
State: other
Zip:
Country: HK
Financial Info
Stage:
Raised Last:
$0
Raised Total:$1B
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Morningside Venture Investments is an investment group that provides industry investments and social responsibility. It was founded in 1986 and is based in Shanghai, China.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2019 | Aural Analytics | Seed Round | 0 |
| 12/2021 | Almond Finance | Seed | 2M |
| 7/2021 | Fount Bio | Series A | 8.2M |
| 6/2021 | Alentis Therapeutics | Series B | 66.8M |
| 4/2019 | Allysta | Series A | - |
| 9/2019 | ZielBio | Series A | 25.1M |
| 11/2018 | Retrotope | Series C | 20M |
| 11/2021 | EasyExpunctions | Series A | 6.3M |
| 4/2019 | CollegeVine | Series B | 24M |
| 3/2021 | Stavvy | Series A | 26.5M |
| 7/2021 | Medrhythms | Series B | 25M |
| 1/2021 | Innodem Neurosciences | Series A | 6M |
| 5/2021 | Neuroelectrics | Series A | 17.5M |
| 5/2021 | Coin Metrics | Series B | 0 |
| 2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
| 1/2017 | Lighthouse.io | Seed Round | 0 |
| 3/2020 | Sensel | Series A | 0 |
| 1/2021 | New Amsterdam Pharma | Series A | 0 |
| 9/2019 | Inotrem | Series B | 43.1M |
| 3/2021 | Apnimed | Series B | 25M |
| 1/2019 | Apic Bio | Series A | 0 |
| 7/2019 | Rockley Photonics | Series E | 52M |
| 5/2021 | Stealth BioTherapeutics | Post-IPO Equity | 30M |
| 1/2020 | Cyted | Seed Round | 10.5M |
| 9/2019 | Meissa Vaccines | Series A | 30M |
| 1/2011 | Clean Membranes | Series A | - |
| 6/2018 | Triastek | Series A | 15.6M |
| 4/2020 | Stealth BioTherapeutics | Post-IPO Equity | 20M |
| 11/2021 | Geneoscopy | Series B | 105M |
| 11/2021 | Generate Biomedicines | Series B | 0 |
| 11/2021 | DeepCure | Series A | 0 |
| 9/2021 | Alamar Biosciences | Series B | 80M |
| 7/2016 | Ignition Design Labs | Series A | 10.3M |
| 6/2018 | ENYO Pharma | Series B | 46.8M |
| 2/2006 | ThingMagic | Equity | 6M |
| 3/2021 | Catalant | Venture Round | 35M |
| 9/2020 | Revolo Biotherapeutics | Series B | 52M |
| 7/2021 | Linus Health | Series B | 55M |
| 10/2022 | Valitor | Series B | 0 |
| 8/2022 | AdvanCell | Series B | 12.5M |
| 1/2020 | Adjuvance Technologies | Series A | 20M |
| 7/2015 | CloudMosa | Series A | 0 |
| 12/2020 | Tallac Therapeutics | Series A | 62M |
| 1/2022 | Big Health | Series C | 0 |
| 9/2019 | Medannex Ltd | Series B | 13.5M |
| 8/2017 | Jitjatjo | Seed Round | 4.4M |
| 10/2021 | BetterUp | Series E | 0 |
| 1/2022 | Casana | Series B | 0 |
| 5/2020 | Atea | Series D | 215M |
| 10/2014 | DNAtriX | Series B | 20M |
| 9/2021 | Homee | Series B | 0 |
| 6/2021 | Triastek | Series B | 0 |
| 11/2016 | CollegeVine | Series A | 3.1M |
| 8/2020 | Prescryptive Health | Series A | 0 |
| 10/2020 | CellCentric | Venture Round | 33M |
| 8/2022 | Epigenic Therapeutics | Seed Round | 0 |
| 3/2022 | Eko | Series C | 0 |
| 8/2020 | F2G | Private Equity Round | 0 |
| 3/2021 | PhoreMost | Series B | 45.3M |
| 4/2017 | CollegeVine | Series A | 3.6M |
| 1/2021 | Rockley Photonics | Venture Round | 65M |
| 7/2020 | neoX Biotech | Venture Round | 10M |
| 6/2020 | Prilenia | Series A | 62.5M |
| 2/2020 | Semios | Venture Round | 75M |
| 1/2022 | Virtue Diagnostics | Series B | 0 |
| 9/2020 | Lele Ketang | Series C | 40M |
| 10/2019 | IM Therapeutics | Series A | 10M |
| 10/2016 | IrisVR | Series A | 8M |
| 4/2017 | Freight Farms | Series B | 6.5M |
| 12/2020 | Curai Health | Series B | 27.5M |
| 11/2021 | Block Renovation | Series C | 0 |
| 8/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
| 8/2017 | Apellis Pharmaceuticals | Series E | 0 |
| 10/2020 | InCarda Therapeutics | Series C | 30M |
| 7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
| 10/2021 | Exo Therapeutics | Series B | 0 |
| 7/2020 | Amylyx Pharmaceuticals | Series B | 0 |
| 2/2022 | Curve Health | Series A | 0 |
| 10/2019 | Cognoa | Series A | 45.1M |
| 12/2021 | Almond FinTech | Seed Round | 2M |
| 1/2019 | Jitjatjo | Series A | 11M |
| 6/2017 | Desora | Series A | - |
| 11/2022 | Resilience Lab | Series A | 0 |
| 7/2020 | Vesigen Therapeutics | Series A | 28.5M |
| 11/2004 | ViOptix | Series C | 0 |
| 11/2021 | ieso | Series B | 0 |
| 12/2014 | Twelve Springs | Series A | 7M |
| 11/2021 | Huckleberry Labs | Series A | 0 |
| 3/2022 | Eko | Series C | 0 |
| 2/2022 | Curve Health | Series A | 0 |
| 2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
| 1/2022 | Casana | Series B | 0 |
| 1/2022 | Big Health | Series C | 0 |
| 1/2022 | Virtue Diagnostics | Series B | 0 |
| 12/2021 | Almond Finance | Seed Round | 0 |
| 11/2021 | ieso | Series B | 0 |
| 11/2021 | Generate Biomedicines | Series B | 0 |
| 11/2021 | Geneoscopy | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
